Atezolizumab in patients with advanced non-small-cell lung cancer who are platinum-doublet ineligible.

O'Sullivan, Hazel; Popat, Sanjay

O'Sullivan, Hazel; Popat, Sanjay.

Affiliation

O'Sullivan H; Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
Popat S; Section of Clinical Trials, Institute of Cancer Research, London, UK; Lung Unit, Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address: sanjay.popat@rmh.nhs.uk.

Lancet ; 402(10400): 426-427, 2023 08 05.

Article in En | MEDLINE | ID: mdl-37423230

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Humans; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Platinum/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Combined Chemotherapy Protocols

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Lancet Year: 2023 Type: Article Affiliation country: Ireland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google